Article
The pathogenesis of mesothelioma is driven by a dysregulated translatome
13 Aug 2021
Abstract excerpt
Malignant mesothelioma (MpM) is an aggressive, invariably fatal tumour that is causally linked with asbestos exposure. The disease primarily results from loss of tumour suppressor gene function and there are no 'druggable' driver oncogenes associated with MpM. To identify opportunities for management of this disease we have carried out polysome profiling to define the MpM translatome. We show that in MpM there is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
